(HealthDay)—Using CYP2C19 genotype-guided dual antiplatelet therapy (DAPT) selection is feasible
Read more
wfamilymedicine.com
Home » Health Problems »
(HealthDay)—Using CYP2C19 genotype-guided dual antiplatelet therapy (DAPT) selection is feasible
Read moreNew research provides the first molecular understanding of why people
Read moreA Children’s-led research team has turned the tables on Schistosoma
Read more“Nightmare bacteria” with unusual resistance to antibiotics of last resort
Read moreA type 1 diabetes genetic score can identify infants at
Read moreA study coordinated by the Institute of Neuroscience of the
Read moreProfessors Peter Brown and Rafal Bogacz in the Nuffield Department
Read moreMouse genes that make human T cells powerful at fighting
Read moreA Zika vaccine could have a substantial effect on mitigating
Read more